Search results
Study shows effectiveness of updated COVID-19 vaccines wanes moderately over time, is lower against...
Medical Xpress· 7 days agoPublished in the New England Journal of Medicine, the study found that COVID-19 boosters targeting ...
On-demand sebetralstat speeds symptom relief in hereditary angioedema, clinical trial finds
Medical Xpress· 2 days agoFor patients with type 1 or type 2 hereditary angioedema, sebetralstat provides faster times to...
A Promising New Blood Test for Colorectal Cancer Is in the Works—Here’s What You Should Know
Self via Yahoo News· 6 days agoThe Shield test is currently available via prescription for a hefty $895. Medicare and most private...
Ozempic may help fight kidney disease, study with Orlando researcher finds
Orlando Sentinel via Yahoo News· 1 day agoAs chronic kidney disease rises nationwide, a new study partially conducted in Orlando suggests...
That Map of the Tongue You Learned in School? Totally Incorrect, According to Science
Food and Wine· 3 days agoA new review published in the New England Journal of Medicine reassesses how ...
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 7 days agoA recent study in the New England Journal of Medicine grabbed the attention of
Hooking up generative AI to medical data improved usefulness for doctors
ZDNet· 17 hours agoResearchers at Heidelberg University Hospital in Heidelberg, Germany, reported in the prestigious New England Journal of< ...
Neoadjuvant immunotherapy for early stage melanoma shows positive results
Medical Xpress· 2 days agoThe results have also been published in New England Journal of Medicine. Standard treatment for ...
Novel Drug Reduces Steroid Need in Congenital Adrenal Hyperplasia
MedPage Today· 4 days agoBoth trials were presented at ENDO 2024, the annual meeting of The Endocrine Society, and...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoNeurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of